Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Platinum Asset Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$160M
Portfolio companies 3
Rounds per year 0.11
Lead investments 1
Exits 1
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Life Science
  • Artificial Intelligence

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bigcolors China, Hong Kong, Hong Kong Island
Bluegrass Growth Fund Partners New York, New York, United States
codecentric AG Düsseldorf, Germany, Nordrhein-Westfalen
Communicade New York, New York, United States
CRYSTAL VENTURES -
eHUB Alberta, Canada, Edmonton
Exact Sciences Madison, United States, Wisconsin
Fitz Gate Ventures Houston, Texas, United States
JettyCove -
Rewired Lausanne, Switzerland, Vaud
Rice Management Company -
Selr8r Birmingham, England, United Kingdom
Staidson Hongkong Investment China, Hong Kong, Hong Kong Island
Symantec Ventures -
TechFund Capital France, Ile-de-France, Paris
the Entrepreneur Fund. -
Transworld Group -
Vertex Pharmaceuticals Boston, Massachusetts, United States
Visionplus Finland, Helsinki, Southern Finland
Will Hunting Capital Beijing, Beijing, China

News
HaemaLogiX Raises $10M in Funding

– haemaLogiX from Sydney is a biotech company developing a drug to treat a rare blood disorder.
– The company raised $10M in Series A funding.
– The round was led by Platinum Asset Management via its Platinum International Health Care Fund.
– The investment will be used to support the manufacturing of the next batch of the Kappa antibody plus the conduct of a higher dose, 30mg/kg, monotherapy study and prepare for two further studies.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Platinum Asset Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 160M
Rounds per year 0.11
Peak activity year 2019
Lead investments 1
Exits 1
Group Appearance index 0.67
Crunchbase icon

Content report

The following text will be sent to our editors: